Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP708641.RAHi-P6HebJiLGWOdBQq2uSF-iFR4qn0nk8lAoHmpvg2M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP708641.RAHi-P6HebJiLGWOdBQq2uSF-iFR4qn0nk8lAoHmpvg2M130_assertion type Assertion NP708641.RAHi-P6HebJiLGWOdBQq2uSF-iFR4qn0nk8lAoHmpvg2M130_head.
- NP708641.RAHi-P6HebJiLGWOdBQq2uSF-iFR4qn0nk8lAoHmpvg2M130_assertion description "[Both the normal-appearing intestinal mucosa and adenomas obtained from dibenzazepine-treated Apc(Min/+) mice had increased goblet cell numbers and Klf4 staining accompanied by reduced cyclin D1 and Ki-67 staining when compared with those from vehicle-treated mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP708641.RAHi-P6HebJiLGWOdBQq2uSF-iFR4qn0nk8lAoHmpvg2M130_provenance.
- NP708641.RAHi-P6HebJiLGWOdBQq2uSF-iFR4qn0nk8lAoHmpvg2M130_assertion evidence source_evidence_literature NP708641.RAHi-P6HebJiLGWOdBQq2uSF-iFR4qn0nk8lAoHmpvg2M130_provenance.
- NP708641.RAHi-P6HebJiLGWOdBQq2uSF-iFR4qn0nk8lAoHmpvg2M130_assertion SIO_000772 19074836 NP708641.RAHi-P6HebJiLGWOdBQq2uSF-iFR4qn0nk8lAoHmpvg2M130_provenance.
- NP708641.RAHi-P6HebJiLGWOdBQq2uSF-iFR4qn0nk8lAoHmpvg2M130_assertion wasDerivedFrom befree-2016 NP708641.RAHi-P6HebJiLGWOdBQq2uSF-iFR4qn0nk8lAoHmpvg2M130_provenance.
- NP708641.RAHi-P6HebJiLGWOdBQq2uSF-iFR4qn0nk8lAoHmpvg2M130_assertion wasGeneratedBy ECO_0000203 NP708641.RAHi-P6HebJiLGWOdBQq2uSF-iFR4qn0nk8lAoHmpvg2M130_provenance.